| Original language | English |
|---|---|
| Pages (from-to) | 148-161 |
| Number of pages | 14 |
| Journal | The Journal of Steroid Biochemistry and Molecular Biology |
| Volume | 125 |
| Issue number | 1-2 |
| DOIs | |
| Publication status | Published - May 2011 |
| Externally published | Yes |
Funding
D.S. is grateful for a Young Talents Grant and the Erika Cremer Habilitation Program from the University of Innsbruck, Austria, Andre Betz, Philipp Schuster, and Sonja Herdlinger are acknowledged for help with preparing the manuscript. We thank the Swiss National Science Foundation for the Grant No. 31003A-124912 to A.O. A.O. has a Chair in Molecular and Systems Toxicology by the Novartis Research Foundation. We are thankful to Prof. Trevor Penning (University of Pennsylvania, Philadelphia, USA) for providing pET-h3 alpha-HSD2 plasmid, 17 beta-HSD5-stably transfected MCF-7 and HEK293 cell lines and 17 beta-HSD5 antibody. We are grateful to Dr. Josef Messinger (Abbott Products GmbH, Hannover, Germany) for the synthesis of the fluorogenic 17 beta-HSD5 substrate. This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.).
Austrian Fields of Science 2012
- 301207 Pharmaceutical chemistry
Keywords
- Pharmacophore screening
- Inhibitor development
- Steroid-dependent disease
- Androgens
- Estrogens
- PROSTAGLANDIN-F-SYNTHASE
- NONSTEROIDAL ANTIINFLAMMATORY DRUGS
- IN-SILICO PHARMACOLOGY
- KETO REDUCTASE AKR1C3
- 11-BETA-HYDROXYSTEROID DEHYDROGENASES
- 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE
- 4-HYDROXYPHENYL KETONES
- BIOCHEMICAL EVALUATION
- CRYSTAL-STRUCTURES
- DISCOVERY